These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 6842577)

  • 1. Defective natural killer (NK) and killer (K) cell function in systemic lupus erythematosus.
    Ewan PW; Barrett HM; Pusey CD
    J Clin Lab Immunol; 1983 Feb; 10(2):71-6. PubMed ID: 6842577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural killer cell activity in families of patients with systemic lupus erythematosus: demonstration of a killing defect in patients.
    Green MR; Kennell AS; Larche MJ; Seifert MH; Isenberg DA; Salaman MR
    Clin Exp Immunol; 2005 Jul; 141(1):165-73. PubMed ID: 15958083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal natural killer cell activity in systemic lupus erythematosus: an intrinsic defect in the lytic event.
    Katz P; Zaytoun AM; Lee JH; Panush RS; Longley S
    J Immunol; 1982 Nov; 129(5):1966-71. PubMed ID: 7119439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A killing defect of natural killer cells as an underlying immunologic abnormality in childhood systemic lupus erythematosus.
    Yabuhara A; Yang FC; Nakazawa T; Iwasaki Y; Mori T; Koike K; Kawai H; Komiyama A
    J Rheumatol; 1996 Jan; 23(1):171-7. PubMed ID: 8838528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired differentiation and cytotoxicity of natural killer cells in systemic lupus erythematosus.
    Park YW; Kee SJ; Cho YN; Lee EH; Lee HY; Kim EM; Shin MH; Park JJ; Kim TJ; Lee SS; Yoo DH; Kang HS
    Arthritis Rheum; 2009 Jun; 60(6):1753-63. PubMed ID: 19479851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of natural killing with antibody dependent cell mediated cytotoxicity in patients with systemic lupus erythematosus.
    Kozlowski SH; Hirsen DJ; Jackson EJ
    J Rheumatol; 1982; 9(1):59-62. PubMed ID: 7086780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotype and function of natural killer cells in systemic lupus erythematosus: excess interferon-γ production in patients with active disease.
    Hervier B; Beziat V; Haroche J; Mathian A; Lebon P; Ghillani-Dalbin P; Musset L; Debré P; Amoura Z; Vieillard V
    Arthritis Rheum; 2011 Jun; 63(6):1698-706. PubMed ID: 21370226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Family study of natural killer cell activity in C1q-deficient patients with systemic lupus erythematosus-like syndrome: association between impaired natural killer cell function and C1q deficiency.
    Tóth J; Starsia Z; Buc M; Stefanovic J
    Immunobiology; 1989 Nov; 180(1):47-54. PubMed ID: 2625354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal macrophages and NK cell cytotoxicity in human systemic lupus erythematosus and the role of interferon and serum factors.
    Zippel D; Lackovic V; Kocisková D; Rovenský J; Borecký L; Stelzner A
    Acta Virol; 1989 Sep; 33(5):447-53. PubMed ID: 2483602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon and natural killer cells in systemic lupus erythematosus.
    Strannegård O; Hermodsson S; Westberg G
    Clin Exp Immunol; 1982 Nov; 50(2):246-52. PubMed ID: 6185256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural and antibody-dependent cellular cytotoxicity in children with systemic lupus erythematosus and juvenile dermatomyositis.
    Miller ML; Lantner R; Pachman LM
    J Rheumatol; 1983 Aug; 10(4):640-2. PubMed ID: 6620266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of corticosteroids on natural killer cell activity in systemic lupus erythematosus.
    Oshimi K; Gonda N; Sumiya M; Kano S
    Clin Exp Immunol; 1980 Apr; 40(1):83-8. PubMed ID: 7389219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural killer cells and interferon responses in patients with systemic lupus erythematosus.
    Tsokos GC; Rook AH; Djeu JY; Balow JE
    Clin Exp Immunol; 1982 Nov; 50(2):239-45. PubMed ID: 6817954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating TCR gammadelta cells in the patients with systemic lupus erythematosus.
    Robak E; Błoński JZ; Bartkowiak J; Niewiadomska H; Sysa-Jedrzejowska A; Robak T
    Mediators Inflamm; 1999; 8(6):305-12. PubMed ID: 10815619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological studies on Crohn's disease. III. Defective natural killer activity.
    Okabe N; Fujita K; Yao T
    J Clin Lab Immunol; 1985 Jul; 17(3):143-6. PubMed ID: 4046002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased DAP12 expression in natural killer lymphocytes from patients with systemic lupus erythematosus is associated with increased transcript mutations.
    Toyabe S; Kaneko U; Uchiyama M
    J Autoimmun; 2004 Dec; 23(4):371-8. PubMed ID: 15571931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of serum from patients with system lupus erythematosus on leukocyte cytotoxicity: modulation of NK activity and ADCC.
    Ytterberg SR; Huard TK; Schnitzer TJ
    J Rheumatol; 1983 Dec; 10(6):906-12. PubMed ID: 6663595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recalcitrant trichophytic granuloma associated with NK-cell deficiency in a SLE patient treated with corticosteroid.
    Akiba H; Motoki Y; Satoh M; Iwatsuki K; Kaneko F
    Eur J Dermatol; 2001; 11(1):58-62. PubMed ID: 11174142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural killer cells in connective tissue disorders.
    Sibbitt WL; Bankhurst AD
    Clin Rheum Dis; 1985 Dec; 11(3):507-21. PubMed ID: 3907953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune complexes in systemic sclerosis; detection by C1q binding, K-cell inhibition and Raji cell radioimmunoassays.
    Hughes P; Cunningham J; Day M; Fitzgerald JC; French MA; Wright JK; Rowell NR
    J Clin Lab Immunol; 1983 Mar; 10(3):133-8. PubMed ID: 6601718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.